MDG1:FRA
MediGene AG
€0.017
arrow_upward
+3.61%(+0.00060) 1D
පොසොන් 30, 22.00.00 ග්රිමවේ+2 · EUR
search
සියලු සංකේත
| සංකේතය | මිල | වෙනස් කිරීම | % වෙනස |
|---|
පුවත් සහ කථා
වෙබ් මූලාශ්ර සහ ප්රවෘත්ති හවුල්කරුවන්ගෙන්
Yahoo Finance
·
මිනිත්තු 23කට පෙර
Bending Spoons (NasdaqGS:BSP) Taps Credit Markets Again As Its Undervalued Narrative Gets Tested
The Dark Side Of The Boom
·
මිනිත්තු 57කට පෙර
The S&P 500 Is Still Standing but the Foundations Are Starting to Crack
CNBC
·
පැය 3කට පෙර
Tokenization could unleash tens of billions of dollars in trapped capital, Nasdaq CEO says
Bloomberg.com
·
පැය 5කට පෙර
Tech Stocks to Fall as OpenAI Sinks US Chipmakers: Markets Wrap
පැතිකඩ
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia